How government-dependent is PUMA BIOTECHNOLOGY, INC.?

In fiscal year 2025, US federal contract obligations equal at least 0.0% of PUMA BIOTECHNOLOGY, INC.'s reported revenue - $0 in federal awards against $228.4M in revenue as filed with the SEC. In fiscal year 2024 the share was at least 0.0%.

Cite as: FACTANKER, https://factanker.com/entity/b38f9edb-828d-4ec4-86d3-058f6b0d23fc/government-dependency

Fiscal year	Revenue (SEC, as filed)	Federal obligations	Share	Data status
FY 2025	$228.4M	$0	≥ 0.0%	contracts only
FY 2024	$230.5M	$0	≥ 0.0%	contracts only

Evidence
Revenue FY 2025: evidence fact 968cc85c… (SEC filing)
Federal obligations FY 2025: sum of 1 award records (USAspending bulk data)
Identity consolidation: CIK 0001401667 · UEI JLJDGN4NRBP3 - linked via evidence-backed same_as facts, see all facts of this organization

Methodology & sources
Revenue: company fiscal year, as filed with the SEC (XBRL concept per evidence fact). Obligations: US federal fiscal year of the award date, consolidated across all registrations of the corporate group. Computed in the database, precomputed weekly - never by a model. Sources: SEC EDGAR, USAspending (public domain).

Not claimed

The two periods do not align exactly: revenue follows the company's fiscal year, obligations the US federal fiscal year (Oct-Sep).
Years marked 'contracts only': grant/assistance awards are not yet loaded - the share is a floor, not the full figure.
Fiscal years without a share: obligations base files not yet loaded; a missing value means missing load, not zero government business.
Obligations are amounts obligated, not amounts paid out.
The share consolidates all registrations of the corporate group via evidence-backed identity links (same_as facts).

PUMA BIOTECHNOLOGY, INC. - all facts · Use this metric in your own models: JSON/API · API/MCP quickstart